GeneQuine to Attend Phacilitate Cell & Gene Therapy Europe Conference, 21-22 September, Berlin

GeneQuine Biotherapeutics, a company focused on the development of a novel gene therapy platform, will attend the Phacilitate Cell & Gene Therapy Europe conference held in Berlin.

The event brings together international stakeholders in the field of cell and gene therapy from the pharma and biotech industry and offers plenty of opportunity for partnering discussions and networking.

(Image by phacilitate-leaders-europe.com)